Publication: Postoperative atrial fibrillation in liver transplantation
Issued Date
2015-01-01
Resource Type
ISSN
16006143
16006135
16006135
Other identifier(s)
2-s2.0-84923294964
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Transplantation. Vol.15, No.3 (2015), 687-694
Suggested Citation
Victor W. Xia, A. Worapot, S. Huang, A. Dhillon, V. Gudzenko, A. Backon, V. G. Agopian, O. Aksoy, G. Vorobiof, R. W. Busuttil, R. H. Steadman Postoperative atrial fibrillation in liver transplantation. American Journal of Transplantation. Vol.15, No.3 (2015), 687-694. doi:10.1111/ajt.13034 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36768
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Postoperative atrial fibrillation in liver transplantation
Abstract
Copyright © 2015 The American Society of Transplantation and the American Society of Transplant Surgeons. Postoperative atrial fibrillation (POAF) is common after major surgeries and is associated with increased morbidity and mortality. POAF after liver transplantation (LT) has not been reported. This study was undertaken to investigate the incidence, impact, and risk factors of POAF in LT patients. After IRB approval, LT between January 2006 and August 2013 at our center were retrospectively reviewed. POAF that occurred within 30 days after LT was included. Patients with and without POAF were compared and independent risk factors were identified by logistic regression. Of 1387 adults LT patients, 102 (7.4%) developed POAF during the study period. POAF was associated with significantly increased mortality, graft failure, acute kidney injury and prolonged hospital stay. Independent risk factors included age, body weight, MELD score, presence of previous history of AF, the vasopressors use prior to LT and pulmonary artery diastolic pressure at the end of LT surgery (odds ratios 2.0-7.2, all p < 0.05). A risk index of POAF was developed and patients with the high-risk index had more than 60% chance of developing POAF. These findings may be used to stratify patients and to guide prophylaxis for POAF in the posttransplant period.